Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05042960 · ClinicalTrials.gov registry record · NA
Computer Screen Properties Study
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT05042960 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 47 participants.
The verdict
NCT05042960, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to identify how various popular methods of changing computer screen settings affect dry eye symptoms (eye pain, grittiness, tearing, burning, etc.). Specifically, this study will examine if there are differences in effects of blue light blocking (F.lux app or night shift) versus reducing screen brightness on the symptoms of dry eye.
Interventions
- OTHER Brightness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2023-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05042960
The ClinicalTrials.gov registry entry for NCT05042960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brightness is the first listed.
NCT05042960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05042960 about?
NCT05042960 is a clinical study titled "Computer Screen Properties Study". The purpose of this study is to identify how various popular methods of changing computer screen settings affect dry eye symptoms (eye pain, grittiness, tearing, burning, etc.). Specifically, this study will examine if there are differences in effects of blue light blocking (F.lux app or night shift...
What is the current status of trial NCT05042960?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2021-09-15. Estimated completion is 2023-01-12.
What interventions are being tested in trial NCT05042960?
The interventions under investigation include: Brightness (OTHER).
Who is sponsoring clinical trial NCT05042960?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.